Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest asthma Stories

2013-06-03 08:28:29

Award recognizes the company's unique advancements in chronic disease management via connected health MADISON, Wis., June 3, 2013 /PRNewswire/ -- Asthmapolis (az-MAP-o-lis), the FDA-cleared mobile health solution for asthma and COPD, today announced it received the Horizon Award in the 2013 TripleTree iAwards for Connected Health. Asthmapolis is a mobile health solution designed to help improve the care of people with asthma, advance understanding of symptoms and triggers and help...

2013-05-29 23:21:07

Allergen identification and avoidance, coupled with patient-centric system processes, may improve early diagnosis and management of asthma. Leawood, KS (PRWEB) May 29, 2013 TransforMED, a national leader in patient-centered medical home transformation, and Group Practice Forum (GPF), an independent network of physician group experts and education professionals, today announced a collaboration to deliver patient-centric clinical education on asthma to primary care medical practices....

2013-05-22 23:25:40

Online retailer provides information on asthma and allergy conditions in honor of awareness month Chicago, IL (PRWEB) May 22, 2013 May is declared National Asthma and Allergy Awareness Month by the Asthma and Allergy Foundation of America (AAFA). Online retailer, Allergy Asthma Technology, wants to remind individuals about Asthma and Allergy Awareness Month, as well as to provide information about asthma and allergy conditions. The AAFA is a non-profit organization in the United States...

2013-05-22 23:20:20

Diet Doc offers new and improved medically supervised hCG diet plans, now capable of providing relief from symptoms or future development of asthma with fast and effective weight loss. Houston, TX (PRWEB) May 22, 2013 Asthma, a disorder that causes the airways of the lungs to narrow and swell causes wheezing, shortness of breath, chest tightness and coughing without sputum production. When an asthma attack occurs, the muscles surrounding the airways become tight and the lining of the air...

Asthma Patients May Breathe More Easily Thanks To Game Changing Drug
2013-05-22 15:08:56

Lee Rannals for redOrbit.com — Your Universe Online Researchers said on Tuesday that a new type of asthma drug could be a potential game changer for patients with moderate to severe respiratory disease. The injectable drug, known as dupilumad, slashed asthmatic episodes by 87 percent in a mid-stage trial of 104 patients. The team wrote about the latest trial's results in the New England Journal of Medicine (NEJM). "Asthma that is difficult to treat is increasingly recognized as...

Almost Half Of COPD Diagnoses Are Wrong
2013-05-22 12:56:06

Peter Suciu for redOrbit.com — Your Universe Online A new study has found that chronic obstructive pulmonary disease (COPD) is over-diagnosed among uninsured patients. Researchers found that over 40 percent of patients being treated for COPD at federally funded clinics did not actually have the disease. COPD is a progressive lung disease that leads to the loss of lung function and is primarily caused by smoking. The disease causes coughing, wheezing, shortness of breath, chest...

2013-05-22 04:21:01

OXFORD, England, May 22, 2013 /PRNewswire/ -- First patients dosed with PSX1002, an orally inhaled, novel drug-only formulation of glycopyrronium bromide designed using Prosonix' particle engineering platform Prosonix, an innovative speciality pharmaceutical company developing a portfolio of inhaled Respiratory Medicines by Design, has initiated a Phase 2 clinical study with PSX1002 that will assess its effect on lung...

2013-05-21 12:28:25

NATICK, Mass., May 21, 2013 /PRNewswire/ -- Five-year data from the Asthma Intervention Research 2 (AIR2) clinical trial presented today demonstrated that the Boston Scientific Corporation (NYSE: BSX) Alair(® )Bronchial Thermoplasty (BT) System continues to show therapy benefits in adult patients with severe uncontrolled asthma. Bronchial Thermoplasty was shown to provide long term asthma control, demonstrated by a sustained reduction in the rate of severe exacerbations (asthma attacks)...

2013-05-21 08:29:42

Phase 2a study of the IL-4R alpha inhibitor, dupilumab, demonstrated 87% reduction in risk of asthma exacerbations in moderate-to-severe asthma patients with elevated eosinophils PARIS and TARRYTOWN, N.Y., May 21, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine published online the positive Phase 2a study results of dupilumab (SAR231893/REGN668) in patients with...

2013-05-21 08:29:37

Boehringer Ingelheim also presents new data from a Phase 2 study demonstrating increased bronchodilation with 5 mcg tiotropium as an add-on therapy in symptomatic patients with moderate persistent asthma at the American Thoracic Society International Conference (ATS 2013) RIDGEFIELD, Conn., May 21, 2013 /PRNewswire/ -- Boehringer Ingelheim today announced data from Phase 2 and Phase 3 studies from the Company's ongoing clinical trial program investigating the efficacy and safety of...


Latest asthma Reference Libraries

Journal of Allergy and Clinical Immunology
2012-05-14 11:51:18

The Journal of Allergy and Clinical Immunology is a medical journal established in 1929 as the Journal of Allergy. It is published by Elsevier. It obtained its current name in 1971. It is the official journal of the American Academy of Allergy, Asthma and Immunology. This journal publishes timely clinical papers, instructive case reports, and detailed examinations of state-of-the-art equipment and techniques to clinical allergists, immunologists, dermatologists, internists, and other...

More Articles (1 articles) »